Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-09-26
1990-11-13
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Lymphokine
424 89, 424 90, 424 92, 424520, A61K 3900, A61K 39085, A61K 3940, A61K 4505
Patent
active
049700715
ABSTRACT:
A method and composition for treating malignant neoplasia and acquired immune deficiency syndrome by once daily administration of a substance (such as human chorionic gonadotropin) characteristic of the tumor or acquired immune deficiency syndrome-afflicted cell in an amount less than the lowest amount necessary to provoke a humoral immune response, as exemplified by the existence of a negative wheal upon subcutaneous administration.
REFERENCES:
patent: 3655874 (1972-04-01), van Hell
patent: 4002738 (1977-01-01), Johnson et al.
patent: 4005194 (1977-01-01), Johnson
patent: 4062942 (1977-12-01), Donini
patent: 4071622 (1978-01-01), Johnson et al.
patent: 4076071 (1978-02-01), Burton et al.
patent: 4196123 (1980-04-01), Rosemberg
patent: 4260736 (1981-04-01), Asano et al.
patent: 4321260 (1982-03-01), Auclair
patent: 4384995 (1983-05-01), Stevens
patent: 4689222 (1987-08-01), McMichael
patent: 4692332 (1987-09-01), McMichael
patent: 4877610 (1989-10-01), McMichael
patent: 4880626 (1989-11-01), McMichael
Acevedo et al., Infection and Immunity, 31: 487-494 (1981).
Akiyama et al., J. Immunol., 131: 3085-3090 (1983).
Bogdanov et al., FEBS Letters, 57: 259-261 (1975).
Bogdanov et al., Byulleten Eksperimental'noi Biologii i Meditsiny, 84: 709-712 (1977).
Cohen, British J. Hospital Medicine, 31: 250-259 (Apr. 1984).
Franklin, Science News, 126: 261 (1984).
Gershon et al., J. Exp. Med., 153: 1533-1546 (1981).
Green, pp. 279-290 in The Potential Role of T--Cells in Cancer Therapy, Fefer et al., eds., Raven Press, New York (1982).
Green et al., Ann. Rev. Immunol., 1: 439-463 (1983).
Herberman et al., Chapter 19 in Immunology III, (Bellanti, ed.), W. B. Saunders Co. (1985), at p. 343.
Herscowitz, Chapter 7 in Immunology III, Bellanti, J. W. Saunders, Philadelphia (1985).
Kellen et al., Cancer, 49: 2300-2304 (1982).
Kellen et al., Cancer Immunol. Immunother., 13:2-4 (1982).
Kellen et al., AACR Abstracts, 23: 235 (Mar. 1982) (Abstract 928).
Klavins, Annals of Clinical & Laboratory Science, 13: 275-280 (1983).
Kolsch, Scand. J. Immunol., 19: 387-393 (1984).
Lewin, Chapter 13 in Genes, John Wiley and Sons, New York (1983).
Loblay et al., Aust. J. Exp. Biol. Med. Sci., 62: 11-25 (1984).
Manzari et al., Surv. Immunol. Res., 1:122-125 (1982).
Miller, Clinical Medicine, 81: 16-19 (1974).
Morgan et al., J. Virol., 46: 177-186 (1983).
Simon et al., JMCI, 70: 839-845 (1983).
Yamauchi et al., J. Exp. Med., 153: 1547-1561 (1981).
Abstract of Examined Japanese Pat. Appln. No. 84 046487 (Published Nov. 13, 1984).
Green et al., Proc. Nat. Acad. Sci. (U.S.A.), 73: 381-385 (1976).
"Bacterial Antigen Made from Staphylococcus", (Leaflet P--108A), Published Nov. 1982 by Delmont Laboratories, Inc., Swarthmore, Pa., 19081.
LandOfFree
Immunotherapeutic methods and compositions employing antigens ch does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunotherapeutic methods and compositions employing antigens ch, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapeutic methods and compositions employing antigens ch will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-775953